These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 2470597

  • 1. Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity.
    Johnson M, Stone DM, Bush LG, Hanson GR, Gibb JW.
    Eur J Pharmacol; 1989 Feb 28; 161(2-3):181-8. PubMed ID: 2470597
    [Abstract] [Full Text] [Related]

  • 2. Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats.
    Stone DM, Hanson GR, Gibb JW.
    Neuropharmacology; 1987 Nov 28; 26(11):1657-61. PubMed ID: 2448703
    [Abstract] [Full Text] [Related]

  • 3. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
    Colado MI, Murray TK, Green AR.
    Br J Pharmacol; 1993 Mar 28; 108(3):583-9. PubMed ID: 7682129
    [Abstract] [Full Text] [Related]

  • 4. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.
    Battaglia G, Yeh SY, De Souza EB.
    Pharmacol Biochem Behav; 1988 Feb 28; 29(2):269-74. PubMed ID: 2452449
    [Abstract] [Full Text] [Related]

  • 5. Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons.
    Schmidt CJ, Taylor VL.
    Eur J Pharmacol; 1988 Oct 26; 156(1):121-31. PubMed ID: 2463176
    [Abstract] [Full Text] [Related]

  • 6. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).
    Slikker W, Ali SF, Scallet AC, Frith CH, Newport GD, Bailey JR.
    Toxicol Appl Pharmacol; 1988 Jul 26; 94(3):448-57. PubMed ID: 2456631
    [Abstract] [Full Text] [Related]

  • 7. Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine.
    Stone DM, Johnson M, Hanson GR, Gibb JW.
    J Pharmacol Exp Ther; 1988 Oct 26; 247(1):79-87. PubMed ID: 2902215
    [Abstract] [Full Text] [Related]

  • 8. Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat.
    Hekmatpanah CR, McKenna DJ, Peroutka SJ.
    Neurosci Lett; 1989 Sep 25; 104(1-2):178-82. PubMed ID: 2573011
    [Abstract] [Full Text] [Related]

  • 9. Effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems of the rat.
    Johnson M, Hanson GR, Gibb JW.
    Biochem Pharmacol; 1987 Dec 01; 36(23):4085-93. PubMed ID: 2446629
    [Abstract] [Full Text] [Related]

  • 10. Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration.
    Johnson MP, Nichols DE.
    Pharmacol Biochem Behav; 1989 May 01; 33(1):105-8. PubMed ID: 2476831
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys.
    Kleven MS, Woolverton WL, Seiden LS.
    Brain Res; 1989 May 29; 488(1-2):121-5. PubMed ID: 2472850
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
    Colado MI, Green AR.
    Br J Pharmacol; 1994 Jan 29; 111(1):131-6. PubMed ID: 7516800
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Chloral hydrate anesthesia antagonizes the neurotoxicity of 3,4-methylenedioxymethamphetamine.
    Schmidt CJ, Black CK, Abbate GM, Taylor VL.
    Eur J Pharmacol; 1990 Nov 27; 191(2):213-6. PubMed ID: 1982264
    [Abstract] [Full Text] [Related]

  • 18. A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivatives.
    Stone DM, Johnson M, Hanson GR, Gibb JW.
    Eur J Pharmacol; 1987 Feb 10; 134(2):245-8. PubMed ID: 2883012
    [Abstract] [Full Text] [Related]

  • 19. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.
    Mokler DJ, Robinson SE, Rosecrans JA.
    Eur J Pharmacol; 1987 Jun 19; 138(2):265-8. PubMed ID: 2887440
    [Abstract] [Full Text] [Related]

  • 20. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB.
    J Pharmacol Exp Ther; 1987 Sep 19; 242(3):911-6. PubMed ID: 2443644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.